Individuals with asymptomatic hemorrhaging infarction or subarachnoid hemorrhage after receiving endovascular treatment for ...

The US Patent and Trademark Office (USPTO) has allowed two new patents for Remedy Pharmaceuticals’ Cirara, aimed at treating LHI.

to treat patients with LHI who experience a wake-up stroke and present with a NIH Stroke Scale Score (NIHSS) ≤ 20, irrespective of whether the patient undergoes EVT. The NIHSS is a widely used ...

The prognostic score was developed based on the ACTUAL (Endovascular Treatment for Acute Anterior Circulation Ischemic Stroke) registry. The validation cohort was derived from the Captor trial.

USA: A new study published in Frontiers in Neurology highlights the potential of automatically quantified follow-up imaging ...

Results Approximately 70% (n=142) of the 204 patients presenting 6–24 hours after last known well with NIH Stroke Scale score ≥6 and harboring an ACLVO are DAWN and/or DEFUSE-3 ineligible, most ...

Results A total of 442 consecutive patients of mean age 66±14 years and median NIH Stroke Scale score of 18 were studied. HV centers were more likely to treat patients after intravenous administration ...